InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by Febbo Phillip G., Chief Scientific & Med Officer. Insider active across 2 companies, notably Veracyte, INC.. In total, 9 filings have been published. Total volume traded: €741k. The latest transaction was filed on 6 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
US$256,7918,349 shares@ US$30.75710.0084% mcap100.0% of flow
Common Stock
SEC:0001649245-25-000005·
€256,7918,349 shares@ €30.75710.0084% mcap50.0% of flow
Common Stock
SEC:0001649245-25-000005:0·
€43,702131 shares@ €333.60130.0002% mcap7.5% of flow
Common Stock
SEC:0001127602-22-011725:0·
03,029 shares0
Common Stock
SEC:0001127602-22-008112:0·
02,851 shares0
Common Stock
SEC:0001127602-22-006616:0·
€157,529446 shares@ €353.20440.0007% mcap58.1% of flow
Common Stock
SEC:0001127602-21-028723·
€157,529446 shares@ €353.20440.0007% mcap26.9% of flow
Common Stock
SEC:0001127602-21-028723:0·
€113,627310 shares@ €366.53760.0005% mcap41.9% of flow
Common Stock
SEC:0001127602-21-019827·
€113,627310 shares@ €366.53760.0005% mcap19.4% of flow
Common Stock
SEC:0001127602-21-019827:0·
9 of 9 declarations
About Febbo Phillip G.
Phillip G. Febbo is the Chief Scientific and Medical Officer at VERACYTE, INC. and ILLUMINA, INC. He oversees the scientific and medical initiatives of the companies, contributing to innovation in the biotechnology field. His expertise is essential for developing new solutions.
